drugset / Trial / NCT00105586

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

NCT00105586

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will determine the efficacy of escitalopram (Lexapro®), an anti-anxiety drug, for generalized anxiety disorder (GAD) and the ways genetics affect response to treatment for GAD in elderly individuals.

Timeline

Start
2004-12
Primary completion
2008-01
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg
Subject Escitalopram Small molecule 20 mg